Εμφάνιση απλής εγγραφής

dc.contributor.author Patel, Girish N. en
dc.contributor.author Patel, R. B. en
dc.contributor.author Patel, H. R. en
dc.date.accessioned 2015-02-02T06:47:08Z
dc.date.available 2015-02-02T06:47:08Z
dc.date.issued 2015-02-02
dc.identifier.uri http://hdl.handle.net/11400/5410
dc.rights Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.source http://e-jst.teiath.gr/ en
dc.subject Metronidazole
dc.subject Μετρονιδαζόλη
dc.subject Sesbania gum
dc.subject Microbially triggered
dc.subject Compression coated
dc.title Formulation and in-vitro evaluation of microbially triggered colon specific drug delivery using sesbania gum en
heal.type journalArticle
heal.classification Medicine
heal.classification Medical physics
heal.classification Ιατρική
heal.classification Ιατρική φυσική
heal.classificationURI http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI http://id.loc.gov/authorities/subjects/sh85083001
heal.classificationURI **N/A**-Ιατρική
heal.classificationURI **N/A**-Ιατρική φυσική
heal.keywordURI http://id.loc.gov/authorities/subjects/sh85084449
heal.language en
heal.access free
heal.publicationDate 2011
heal.bibliographicCitation Patel, G.N., Patel, R.B. and Patel, H.R. (2011). Formulation and in-vitro evaluation of microbially triggered colon specific drug delivery using sesbania gum. "e-Journal of Science & Technology". [Online] 6(2): 33-45. Available from: http://e-jst.teiath.gr/ en
heal.abstract The aim of the present study is to develop colon targeted drug delivery systems for metronidazole using sesbania gum as a carrier. Matrix, enteric coated and compression coated tablets of metronidazole containing various proportions of sesbania gum were prepared. All the formulations were evaluated for the hardness, drug content uniformity, and were subjected to in vitro drug release studies. Matrix tablets and enteric coated tablets of metronidazole released 41–71% and 25–28% of the metronidazole, respectively, in the physiological environment of stomach and small intestine depending on the proportion of sesbania gum used in the formulation. Both the formulations failed to control the drug release within 5 hr. The compression coated formulations (CS2) released less than 5% of metronidazole in the physiological environment of stomach and small intestine. When the dissolution study was continued in simulated colonic fluids, the compression coated tablet with 150 mg of sesbania gum coat released another 76% of metronidazole after degradation by colonic bacteria at the end of 12 hr. en
heal.publisher Νερατζής, Ηλίας el
heal.publisher Σιανούδης, Ιωάννης el
heal.journalName e-Journal of Science & Technology en
heal.journalName e-Περιοδικό Επιστήμης & Τεχνολογίας el
heal.journalType peer-reviewed
heal.fullTextAvailability true


Αρχεία σε αυτό το τεκμήριο

Οι παρακάτω άδειες σχετίζονται με αυτό το τεκμήριο:

Εμφάνιση απλής εγγραφής

Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες Εκτός από όπου ορίζεται κάτι διαφορετικό, αυτή η άδεια περιγράφεται ως Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες